Biotex Pharma Investments, LLC

Insider

First SEC filing: July 2, 2009 · Latest: July 2, 2009

On this page

Insider at

0 buys (P) 0 sells (S) Net: $0 + 4 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

4 other filings hidden

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
Oct. 9, 2009	SNGX	D	335,000	$0.32	$107,200	17,665,000 Direct	-1.86%	Disposed	-100.0% (price as of 2026-08-21)
Oct. 1, 2009	SNGX	D	750,000	$0.31	$232,500	18,000,000 Direct	-4.00%	Disposed	-100.0% (price as of 2026-08-21)
Sept. 28, 2009	SNGX	D	250,000	$0.26	$65,000	18,750,000 Direct	-1.32%	Disposed	-100.0% (price as of 2026-08-21)
Sept. 18, 2009	SNGX	D	250,000	$0.27	$67,500	18,750,000 Direct	-1.32%	Disposed	-100.0% (price as of 2026-08-21)
Aug. 11, 2009	SNGX	S	500,000	$0.20	$100,000	19,000,000 Direct	-2.56%	Disposed	-100.0% (price as of 2026-08-21)
July 30, 2009	SNGX	S	500,000	$0.20	$100,000	19,500,000 Direct	-2.50%	Disposed	-100.0% (price as of 2026-08-21)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Securities held when first becoming an insider, per SEC Form 3.

Date	Ticker	Security	Shares	Ownership
July 2, 2009	SNGX	Common Stock, Par Value $0.001 per share	20,000,000	Direct